Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05690061 · ClinicalTrials.gov registry record · NA
Beef and Plant Burger Metabolomics Study
A NA study of Inflammatory Response, sponsored by Utah State University.
- Active
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT05690061: Active NA study of Inflammatory Response, sponsored by Utah State University.
NCT05690061 is a NA study of Inflammatory Response that is active but no longer recruiting, run by Utah State University. The registered enrollment target is 36 participants, below the 176-participant average among 16 other Inflammatory Response trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05690061, a NA study of Inflammatory Response, is active but no longer recruiting, sponsored by Utah State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effects of meat on inflammatory and metabolite profiles in middle-aged individuals after an acute meal. Up to 36 adults, who are overweight or obese and between 30-60 years old will undergo a consent/screening visit, followed by three study visits. On separate visits to the clinical research facilities at the Center for Human Nutrition Studies, participants will consume either 9 oz (250 grams) of cooked grain-fed beef, grass-fed beef, or a plant-based meat alternative (Impossible Burger). Blood will be drawn prior to food consumption and three more times after eating the meal at 1h, 3h, and 5h after participants finishing their meal. The investigators will use those blood samples to determine the impacts of these foods on inflammatory markers and metabolite profiles (compounds that circulate in our blood such as amino acids, fatty acids, and phenolics).
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Grain-Fed Beef Hamburger
- DIETARY_SUPPLEMENT Grass-Fed Beef Hamburger
- DIETARY_SUPPLEMENT Impossible BurgerTM
Study Locations (1)
Utah
- Center for Human Nutrition Studies - Logan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2024-12-16 |
| Phase | NA |
What the registry record for NCT05690061 still lists
NCT05690061 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 176-participant average among 16 other Inflammatory Response trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Inflammatory Response appearing as the primary indexed condition, and to 3 interventions - of which Grain-Fed Beef Hamburger is the first listed.
NCT05690061 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT05690061 about?
NCT05690061 is a clinical study titled "Beef and Plant Burger Metabolomics Study". The purpose of this study is to determine the effects of meat on inflammatory and metabolite profiles in middle-aged individuals after an acute meal. Up to 36 adults, who are overweight or obese and between 30-60 years old will undergo a consent/screening visit, followed by three study visits. On se...
What is the current status of trial NCT05690061?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2023-02-01. Estimated completion is 2024-12-16.
What conditions does trial NCT05690061 study?
This clinical trial studies the following conditions: Inflammatory Response.
What interventions are being tested in trial NCT05690061?
The interventions under investigation include: Grain-Fed Beef Hamburger (DIETARY_SUPPLEMENT), Grass-Fed Beef Hamburger (DIETARY_SUPPLEMENT), Impossible BurgerTM (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05690061?
This trial is sponsored by Utah State University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05690061 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammatory Response
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05690061's enrollment target sits among peer trials
36 13th of 16 higher than 4 of 16 other Inflammatory Response trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammatory Response trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Menthol, Inflammation, and Nicotine Transition Study
RECRUITING · NA
-
Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise
RECRUITING · NA
-
Association Between Body Composition and Pain in Spinal Cord Injury
RECRUITING · NA
-
Social Experiences and Demographic Factors in the Regulation of Immune Cells
RECRUITING · NA
-
Daoist Zhanzhuang and Human Flourishing
RECRUITING · NA
-
Investigating Age-dependent Effects of Egg Intake on HDL and Immune Profiles
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI